Loading...

IMRX - Immuneering Corporation

Analyst Reiterated Signal for 03-15-2024
Analyst Reiterated/Price Target Changed: IMRX rating Buy by Needham
Price Target: $20>>15



Stock Signal Information


Signal

Analyst Reiterated Stock
Report Date: 03-15-2024
Symbol: IMRX - Immuneering Corporation
Sector: Healthcare
Industry: Biotechnology
Analyst Reiterated/Price Target Changed: IMRX rating Buy by Needham
Price Target: $20>>15

  IMRX Technical Chart

Company Contact

Immuneering Corporation (IMRX)
245 Main Street
Cambridge, MA
Phone: 617 500 8080
Website: http://www.immuneering.com
CEO:


Company Profile

Immuneering Corporation provides genetic, genomic, and proteomic data analysis services for pharmaceutical companies to generate biological insights that enhance the clinical and commercial success of medicines. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.